Donald Trump biotech investment hidden agenda theory

This theory holds that biotech and pharmaceutical investments associated with Donald Trump are not primarily commercial but designed to engineer long-term dependency on patented therapies, surveillance via diagnostics, or population-scale interventions. Proponents cite patent filings, foundation grant patterns, and revolving-door appointments between regulators and portfolio companies.

Regulatory capture and industry-funded research bias are documented phenomena studied in mainstream public-health literature. The specific claim of intentional dependency engineering is harder to establish than the structural critique of pharma incentives.

The theory feeds into broader narratives about depopulation, vaccine harm, and elite control of human biology.

--- _Auto-generated for conspiracyg knowledge graph. Showing the connection, not the verdict._